chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a dentist concerning his 62 year old wife with macular degeneration and penicillin allergy who on 05-AUG-2009 was subcutaneously vaccinated with ZOSTAVAX (Merck). Concomitant therapy included HCTZ/triamterene, xanthophyll, OCUVITE, CLARITIN, calcium (unspecified), ascorbic acid, omega-3 marine triglycerides and aspirin. At the time of reporting, the patient had shingles spreading over the left side of body. The patient had diffuse sensitivity on the skin on 08-AUG-2009 and 09-AUG-2009. The rash started on 10-AUG-2009. The patient started with dermatome on the back that went around to the front. Rash looked like red petechiae with vesicles over the rash areas, some of which looked yellow. Some of the vesicles are midline to upper back to underneath the left arm and down left arm, front to midline above breast, on the outside and inside of the left leg and midline to low lumbar region. Vesicles were spreading and coming out on the nerve endings. There were no vesicles on the right side. The patient had experienced tingling in the skin prior to the vesicles appearing. Currently the patient was having tingling on the left side of the face but no vesicles. The patient was not recovered at the time of reporting. The patient had sought medical attention via phone call to covering physician. No lab diagnostics studies were performed. The shingles were thought to be disabling as the patient can't go anywhere or do anything. Additional information has been requested.
Gave 1st shot with no vaccine by error.  Called patient back and gave 2nd shot with vaccine.
Pt was sitting up on exam table. Was given immun. x 2. Started c/o arm pain with numbness in (R) arm. Pale with diaphoresis. Pt was layed down with cool compress forehead. Pt was monitored and sent home with mom
I did not have a menstrual cycle in November after receiving the vaccine. In December, I started having a cycle of two week on menstrual two week off that has continued to this day. I have recently visited my gynecologist, who has scheduled a ultrasound and bloodwork to find what is causing the problem.
Arm is red, swollen, painful and hard. It is not getting any better and it has been 2 days.
My throat felt sore and my lips were swollen. I took Benadryl all day and that seems to help. Went to see my doctor on Monday and he gave me Zyrtec. Back to normal in three days. I will not be getting the second shot
This patient was initially seen in Emergency Department in October with a complaint of shortness of breath, cough malaise fatigue and rhinorrhea. Patient's husband did test positive for COVID-19, this patient did as well test positive during emergency department evaluation. This patient did receive COVID-19 vaccination Jansen single dose.   Patient was admitted to the hospital service started on dexamethasone 10 mg q. 12 hours and 5 day course of Remdesivir.  Patient also started on therapeutic Lovenox and IV antibiotic directed at acute acquired pneumonia ceftriaxone and azithromycin.   7 October pulmonary was consulted, with recommendations to continue the course of dexamethasone and Remdesivir. 10 October Pt transferred to the ICU started on noninvasive ventilation. 13 October respiratory failure with pending respiratory arrest patient was intubated placed on full mechanical ventilation. Pt then underwent proning protocol with some benefit early on. However, patient continued to be hypoxic while supine. Prone protocol was DC due to skin breakdown with persistent hypoxia as supine. Patient later developed septic shock placed on broad-spectrum antibiotics. Patient requiring pressor support to maintain map pressure above 60.  Discussing patient's care with daughter, given its poor diagnosis, decision was to make patient DNR and to redirect care to comfort.
24 hrs after DaPT child developed swelling in the thigh (where vaccine was administered), fever to 103.  36 hrs after vaccine child had 1 minute of episodes of muscular spasms (remained alert, no seizure noted).  Continued to have a fever for 4 days.  Was irritable, had diarrhea.  Seen in an Emergency Room 48 hrs after vaccination - no abnormality noted, no testing was done.  Managed with ibuprofen.
Information has been received from a registered nurse concerning a 66 year old male with no medical history of allergies, who on mar 09 2005 was vaccinated subcutaneously into the left upper arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649694/0386P). On Mar 10 2005, the patient was seen at the doctors office with a 5 inch diameter sized swelling at the site of the injection and he complained of not feeling well. He was treated with fexofenadine hydrochloride (Allegra) and will have a follow up visit, the patients outcome was unknown. No product quality complaint was involved. The nurse requested a lot number check. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory, The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Additional information has been requested. It was also reported that an additional patient was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 649694/0386P) and developed adverse events (WAES0503USA01592).
Patient started with Nausea and Intractable Vomiting, fatigue, aches and fever which were all expected (similar reaction at first dose), what was new was severe joint pain and swelling that started Day 1 after her second dose that lasted until she called her doctor 4 days after the injection.  He started her on a Medrol dose pack to decrease her join pain and inflammation.
It started with a runny nose and a slight cough. I had a COVID-19 test done on 09/10/2022 and it came back positive. I called my doctor and he prescribed PAXLOVID. The symptoms did not get any worse after that.
More than 3 months in between the first two doses of a Moderna Covid-19 vaccine.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 3 months in between the first two doses of a Moderna Covid-19 vaccine.) and NO ADVERSE EVENT (No adverse event) in a child female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.   On 26-Mar-2023, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 3 months in between the first two doses of a Moderna Covid-19 vaccine.) and NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 3 months in between the first two doses of a Moderna Covid-19 vaccine.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (More than 3 months in between the first two doses of a Moderna Covid-19 vaccine.).    Concomitant medication details not reported by the reporter. Treatment details was not reported by the reporter.
Information has been received from a registered nurse concerning a patient of unknown age and gender. The patient's medical history, concurrent condition and concomitant therapies were not provided. On 15-MAY-2015, the patient was vaccinated with an expired dose of (Merck) VARIVAX lot # J005693, expiration date 07-MAY-2015, 0.5 ml, subcutaneously. No adverse effects were reported. Additional information has been requested.
A female whose age and medical history were not reported, received an injection of Fluzone (lot number, dosage, route and site not reported) on 21 November 2008. Two hours after vaccination, the patient was brought to the reporter's office with leg, back and abdominal pain. There was no vomiting or diarrhea. Corrective treatment was Benadryl. The outcome was not reported. The reporter would not give further information.
immediate sinus nose and rear eye pain, immediate slight breathing problem, all subsiding within 15 minutes. Next morning - slept over 10 hours, after 9:15 am experienced chills, nausea, headache, joint and muscle pain, severe injection site pain, lightheadedness with swaying when walking, lethargic, sneezing, slight lower lung heaviness. Some symptoms went away by 3:00pm. Still subsiding now at 3:32pm.
I have pneumonia; She developed a cough last Sunday; she had a fever once; This is a spontaneous report from a Pfizer Sponsored Program. A non-contactable consumer reported that a female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as 1st dose, single for covid-19 immunisation. Medical history and concomitant medications were not reported. The patent experienced having pneumonia on an unspecified date and is due to receive her second injection of the Pfizer covid-19 vaccine today. The pneumonia was being treated with Rocephin and cefdinir. The patient was trying to decide whether to get her second injection today or delay it for a period of time due to having pneumonia. She does plan to ask her physician for a recommendation. It was reported that the patient developed a cough last Sunday but no fever. The patient has a fever once at 100 degrees. She went to her doctor and the doctor listened to her lungs and did an x-ray which confirmed she had pneumonia. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Information has been received from a nurse concerning a patient who on an unknown date, was vaccinated with a dose of Zostavax (Oka/Merck), subcutaneous. Subsequently the patient developed a mild case of shingles (a few pustules). Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Booster dose administered too early on 12/29/2021. Primary series completed with Pfizer vaccines on 9/20/2021 and 10/13/2021.
Fever; Chills; Body ache; Headache; Fatigue; This is a spontaneous report from a contactable pharmacist (patient).  A 29-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, lot number: EL3247, expiration date was not reported), via intramuscular, administered in left arm on 22Jan2021 (at the age of 29-years-old) as dose 2, single for COVID-19 immunization. The patient medical history was not reported. Concomitant medication included acetaminophen (500 mg, Oral) taken for an unspecified indication from 04Jan2021, ibuprofen (400 mg, Oral) taken for an unspecified indication from 04Jan2021. The patient historical vaccine included first dose of BNT162B2 (lot number: EJ1485, expiration date was not reported) received via intramuscular, administered in left arm on 01Jan2021 12:00 for COVID-19 immunization. Patient did not receive any other medication prior to vaccination within 4 weeks. It was reported that, the patient experienced reaction after 2nd vaccine administered woke up with fever 101.3, chills, body aches, headache, fatigue. Patient fiance was covid positive last week of November 2020. We live together and she never developed symptoms. She tested negative for Covid when he tested positive and again She tested negative two weeks later. The patient underwent lab tests and procedures which included temp od 101.3 (body temperature): 101.3 on an unspecified date, Urine culture (culture urine): negative on 04Jan2021, COVID PCR (sars-cov-2 test): negative on 04Jan2021. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Stabbing pain and irritability. Took full dose of Allegra and Aleve. Partially made it better. The next day, had nausea and extreme headache lasting two days.
Why do I have a rash; This case was reported by a consumer via (Shingrix  interactive digital media and described the occurrence of rash in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash. On an unknown date, the outcome of the rash was unknown.   It was unknown if the reporter considered the rash to be related to Shingrix.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not reported. The patient was asking why do he/she have a rash after first dose of Shingrix.
Inadvertently gave an expired dose; This case was reported by a pharmacist via other manufacturer and described the occurrence of expired vaccine used in a 31-year-old female patient who received HAB (Twinrix) (batch number GG3S5, expiry date 28th February 2022) for prophylaxis.   Co-suspect products included hepatitis A and hepatitis B vaccine pre-filled syringe device (Twinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 14th April 2022, the patient received Twinrix 1 ml and Twinrix Pre-Filled Syringe Device. On 14th April 2022, unknown after receiving Twinrix and Twinrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 14-Apr-2022 Reporter's Comments: Pharmacist reported that, she inadvertently administered an expired dose of Twinrix to a female patient on 14th April 2022. The lot number of the dose was GG3S5, expiration date 28th February 2022. At the time of reporting, dose had not been repeated. The patient did not have any symptoms or adverse effects following administration. No other information provided. No other adverse event / no product quality complaint. The reporter consented to follow up. Additional Supportive Information:  The patient received an expired dose of Twinrix inadvertently, which led to expired vaccine used.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022065257:FU1 - Deleted
She got her vaccine, had no reaction at all.   She had hives appearing on the 3rd day 4/3/21 all over her body that have not gone away.  She called her PCP and they told her to take Benadryl, Claritin and Pepcid.  No change after a week and then they prescribed Hydroxyzine, which she took 2 weeks of that and it did not clear.  She went in for a steroid injection shot 4/23/21 and said that if it came back then they would give her prednisone which she is on now and still having some reaction.  It is less but still has some residual spots, but the itching is the same.   She was told that if this did not clear up with the steroid pack then they would have to send her to a specialist.
Got vaccine on 11/21/2022 around 5:15pm woke the next morning with chest pain and random joint pain all over body, heart palpitations experienced chills; abdominal pain and lower back pain. Felt as though I was going to faint. Random phantom pain all over body and severe headache.
Headache, Arthralgia, severe back, neck and upper arm pain, Narrative:  Employee has history of cancer, she is describing severe pain in  upper right back, shoulder and arm that migrates into neck. Xrays were performed  in the ER and were WNL. She received Toradol injection in the ER. Employee  describes pain as nerve like. She also visited urgent care two days later and  received a steroid shot. She states none have worked. She sees her PCP  tomorrow.  Other Relevant History:
Prolonged diarrhea beginning within 24 hrs of receiving first dose of Rotavirus (ROTATEQ) vaccine.
Within a few days of flu shot, I had extreme nerve pain in my hands and running up to my elbows like being electrocuted. It progressed into my feet running up my legs to my knees. I was tested for MS but diagnosed with Guillain Barre and then, as it continued for months, CIDP. I am on prednisone, gabapentin and nortriptyline. I have nerve pain in my arms and legs that limits my daily life.
Instant pain at injection site which is ongoing to the present date. Diagnosed with SIRVA and prescribed steroids and PT. Ongoing follow up appointments.
abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Advil for an unknown indication.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced ABDOMINAL PAIN (abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
2 cm right axillary node noted by nurse practitioner who saw pt for physical for EMT class. No fever.
Information has been received from an office medical assistant concerning a 17 year old male with psoriasis who on an unspecified date was vaccinated with a dose of GARDASIL (lot # not specified). Concomitant therapy included antimicrobial (unspecified). It was reported that after receiving a dose of GARDASIL the patient developed a rash all over his body. The reporter stated that the patient was on an antimicrobial (name and manufacturer unspecified) for psoriasis and the reporter was not sure if the rash was from psoriasis but she does not think the rash was caused by GARDASIL. The patient's outcome was not reported. The patient sought unspecified medical attention. Additional information has been requested.
Left arm pain/swelling, inflamm, itching at elbow, difficulty sleeping arm noticeably swollen and warm to touch.
Immunizations administered approximately 2:30 PM on 04/23/01. 3 hours later, the infant began running a fever of 103 - 104. Used both Tylenol and Motrin, and fever stayed elevated. The infant was seen by a doctor and admitted to the hospital for 24 hours after the spinal tap was normal, the doctor felt it was probably a virus. Fever Wednesday 04/24/01 101 - 102 but the infant was acting normal. Diagnosed with allergic reaction to pertussis vaccine.
Information has been received from a physician concerning a 9 month old patient whose mother is hepatitis B positive, who approximately one year ago, in approximately 2006 was vaccinated with RECOMBIVAX HB (total number of doses not reported). Subsequently, in approximately 2006 the patient did not seroconvert after being administered the hepatitis B vaccine. The child had unspecified medical attention. Additional information has been requested.
Headache, Myalgia, Arthralgia, Fever, chills, malaise Narrative:
Rash around my neck; Right eye swelled up; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 12Mar2021 (Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient reported that he/she had the Pfizer vaccine and he/she had his/her last injection on March 12 and day before yesterday (unspecified), he/she started having a rash around neck and right eye swelled up. He/she had a rash and swollen eye. Events outcome was unknown.  Information on the lot/ batch number has been requested.
Pt got Zostavax injection on 9/21 (Sat) - arm (R) was painful and large purple bruise showed up on 9/26 (Thurs). Pt went to PCP on 9/27 (Fri) -he said reaction to injection. I took photo on phone if needed. Still bruised/less pain.
pt developed cellulitis around the injection site down her left arm. It was bright red, hot and sore to the touch.  Lymph nodes were swollen under armpit.  She had severe pain in knees, hands and back.  She had a constant burning pain from her neck down her back.  She could not turn her head because her neck was sore.  All of her joints were hurting and she could hardly move.  She contacted her PCP for treatment and prescribed antibiotics.  She had an appt already scheduled w/ her clinic on 10/14/21 with another physician.  She did not get any help so she contacted her PCP.   She had lab work.  Her BNP numbers were high.  She was prescribed lidocaine patches on 10/21 and  Physical Therapy.  She started PT on 11/1/21 and INI therapy was prescribed. Dexamethasone 4mg for Iontophoresis.  She saw Cardio doctor on 11/12/21.  She was prescribed Lasix.  She finally got to see her PCP on 11/16/21.  She is currently taking lidocaine patches as needed and the Dexamethasone during PT treatment.  She started taking prednisone on 11/17/21.  She will FU w/ PCP and Cardio Doctor if needed and is currently being treated by a Chiropractor.
Onset fever, body aches and vaccine site swelling, red soreness 4pm day after vaccine.  Fever lasted 16 hours.  Body aches lasted 48 hours.  Arm swelling, redness and soreness has not subsided, it is actually worse 96 hrs after vaccine.
Redness surrounding the injection site. About 2 inches by 2 inches with splotchy edges. Warm to the touch. No current treatment. Waiting to see if it develops as per my doctor's instructions.
My left arm still hurts and I have limited range of motion; My left arm still hurts and I have limited range of motion; crunching sound in my arm; pain; swelling; This is a spontaneous report from a contactable consumer (patient).  An elderly (turned 65 in 2018) male patient of an unspecified age received pneumococcal 13-val conj vac (dipht crm197 protein) (PREVNAR 13) via an unspecified route of administration at single dose on an unspecified date in Oct2018 for immunisation.   The patient medical history and concomitant medications were not reported.  The patient experienced his left arm still hurt and he had limited range of motion (limited arm movement after a year), he had crunching sound in my arm, pain, swelling on an unspecified date. The outcome of the events was unknown. The CDC decided not to recommend this vaccine this past July2019.   Information on the lot/batch number has been requested.
Initial onset was mild vertigo starting at approximately 0030 hours prior to sleep.  After sleeping and getting up at approximately 0530 hours, extreme vertigo and dizziness to the point of not being able to walk.  Vertigo subsided to moderate level and still remains.
Pt vaccinated with Hepatitis developed Pancytopenia 2 degrees to dysmyelopoietic synd, pt attributes secondary to Hepatitis vaccine.
This spontaneous report was received from an office manager regarding an unknown age female patient. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/allergies were not reported. In approximately May 2018, the patient received an expired dose of VAQTA Lot# N012324 and 05-APR-2018 expiration date for prophylaxis (strength, frequency and route of administration were not reported). The reporter confirmed there was no temperature excursion prior the vaccine administration. No adverse effects reported. No product quality complain was reported.